Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 72888-180

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 72888-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 01)

A chart depicting pharmacokinetic fold changes and 90% confidence intervals for various analytes when interacting drugs are co-administered, relative to reference values. It includes drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, desipramine, haloperidol, caffeine, tolbutamide, and lithium, with recommendations on dose adjustments or clinical significance.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 02)

Chemical structure diagram of venlafaxine hydrochloride, showing its molecular framework with labeled chemical groups including the methoxy group, cyclohexane ring, and hydroxy moiety.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 03)

A scatter plot showing fold change and 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite pharmacokinetic parameters (Cmax and AUC) across various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents change relative to the reference value.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 04)

A chart depicting the pharmacokinetic interaction of venlafaxine with various drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. It shows fold changes with 90% confidence intervals for venlafaxine's Cmax, AUC, and ODV relative to reference values. The chart illustrates variability in drug interactions affecting venlafaxine's pharmacokinetics.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 05)

A chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, desipramine, haloperidol, caffeine, toltubamide, and lithium. The x-axis shows change relative to a reference value, illustrating interactions with VENLAFAXINE HYDROCHLORIDE.*

FDA Label Image

Venlafaxine-05 (Eaaae405 79cc 4797 A732 23c033432f61 06)

Label for Venlafaxine HCl Extended-release Capsules, USP 37.5 mg, oral capsules in a package of 30. The label shows dosing strength, manufacturer (Inventia Healthcare Limited), and distributor (Advagen Pharma Limited). It includes storage instructions and a pharmacist dispensing note. The label features the NDC 72888-179-30 and barcodes.*

FDA Label Image

Venlafaxine-06 (Eaaae405 79cc 4797 A732 23c033432f61 07)

Label for Venlafaxine HCl extended-release capsules, USP 75 mg, containing 30 capsules. The label includes dosage form and strength, pharmacist dispensing instructions, storage conditions, manufacturer and distributor information, NDC number 72888-180-30, and a barcode. The product is labeled by Advagen Pharma Ltd.*

FDA Label Image

150 mg (Eaaae405 79cc 4797 A732 23c033432f61 08)

Label for Venlafaxine HCl Extended-release Capsules, USP 150 mg by Advagen Pharma Ltd. The label includes dosage form, strength, quantity of 30 capsules, NDC 72888-181-30, storage instructions, manufacturer and distributor information, and a barcode. It also contains a pharmacist instruction and safety sealing note.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 181 1)

VENLAFAXINE HYDROCHLORIDE 37.5 mg extended release oral capsules, labeled by Advagen Pharma Ltd. The image shows a white and orange capsule with imprint details visible on the capsule body.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 181 2)

Packaging label for VENLAFAXINE HYDROCHLORIDE extended release capsules by Advagen Pharma Ltd. The label shows the dosage strengths 75 mg and 37.5 mg, and indicates the product is for oral use as a prescription drug. The label background is primarily white with orange and green accents, displaying dosage and product name clearly.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 181 3)

VENLAFAXINE HYDROCHLORIDE extended release capsule packaging label. The label displays the product name, dosage form as capsules, and the manufacturer Advagen Pharma Ltd. It shows strengths including 150 mg, 75 mg, and 37.5 mg. The design includes blue and white colors with text detailing the drug name and strength.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 38 1)

VENLAFAXINE HYDROCHLORIDE 75 mg extended release capsules in a blister pack. Each capsule is labeled with the strength and the manufacturer Advagen Pharma Ltd. The packaging includes multiple capsules arranged in two rows within a transparent blister sealed by a foil backing.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 38 2)

VENLAFAXINE HYDROCHLORIDE 150 mg extended-release capsules in a blister pack from Advagen Pharma Ltd. The label shows 10 capsules arranged in two rows of five each, with blue and white capsule coloring. The packaging includes dosage strength and labeler information.*

FDA Label Image

Image (Eaaae405 79cc 4797 A732 23c033432f61 38 3)

VENLAFAXINE HYDROCHLORIDE 150 mg extended release capsule bottle label by Advagen Pharma Ltd. The label shows the drug name, dosage strength, dosage form, and volume of the bottle container in a typical pharmaceutical label format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.